Literature DB >> 30165603

Upper Gastrointestinal Tract Involvement in Crohn's Disease: Frequency, Risk Factors, and Disease Course.

Thomas Greuter1, Alberto Piller1, Nicolas Fournier2, Ekaterina Safroneeva3, Alex Straumann1, Luc Biedermann1, Sébastien Godat4, Andreas Nydegger5, Michael Scharl1, Gerhard Rogler1, Stephan R Vavricka1, Alain M Schoepfer4.   

Abstract

BACKGROUND: The frequency of upper gastrointestinal [GI] tract involvement in Crohn`s disease [CD] has been reported with a large variation. Risk factors and disease course of patients with upper GI tract involvement remain largely elusive.
METHODS: Data on CD patients in the Swiss Inflammatory Bowel Disease Cohort were analysed. Patients with upper GI tract involvement were compared with controls. Logistic regression models for prediction of upper GI tract involvement and Cox proportional hazard models for occurrence of complications were computed.
RESULTS: We included 1638 CD patients, of whom 107 [6.5%] presented with upper GI tract involvement at the time of diagnosis and 214 [13.1%] at any time. Prevalence of such involvement at diagnosis increased over time [5.1% for 1955-95 versus 11.3% for 2009-16]. In a multivariate logistic regression model, male sex and diagnosis between 2009 and 2016 [versus before 1995] were independent predictors for presence of upper GI tract involvement at CD diagnosis (odds ratio [OR] 1.600, p = 0.021 and OR 2.686, p < 0.001, respectively), whereas adult age was a negative predictor [OR 0.388, p = 0.001]. Patients with upper GI tract involvement showed a disease course similar to control patients (hazard ratio [HR] for any complications 0.887, (95% confidence interval [CI] 0.409-1.920), and a trend towards occurrence of fewer intestinal fistulas [log-rank test p = 0.054].
CONCLUSIONS: Prevalence of upper GI tract involvement has been increasing over the past decades. Male sex and young age at diagnosis were identified as the main predictive factors for such involvement at CD diagnosis. Involvement of upper GI tract did not result in a worse outcome.

Entities:  

Mesh:

Year:  2018        PMID: 30165603     DOI: 10.1093/ecco-jcc/jjy121

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  9 in total

1.  Guidelines for the management of patients with Crohn's disease. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in Gastroenterology.

Authors:  Michał Łodyga; Piotr Eder; Magdalena Gawron-Kiszka; Agnieszka Dobrowolska; Maciej Gonciarz; Marek Hartleb; Maria Kłopocka; Ewa Małecka-Wojciesko; Piotr Radwan; Jarosław Reguła; Edyta Zagórowicz; Grażyna Rydzewska
Journal:  Prz Gastroenterol       Date:  2021-11-19

Review 2.  Surgical management of Crohn's disease: a state of the art review.

Authors:  Elise Maria Meima-van Praag; Christianne Johanna Buskens; Roel Hompes; Wilhelmus Adrianus Bemelman
Journal:  Int J Colorectal Dis       Date:  2021-02-02       Impact factor: 2.571

3.  Maximizing the diagnostic information from biopsies in chronic inflammatory bowel diseases: recommendations from the Erlangen International Consensus Conference on Inflammatory Bowel Diseases and presentation of the IBD-DCA score as a proposal for a new index for histologic activity assessment in ulcerative colitis and Crohn's disease.

Authors:  Corinna Lang-Schwarz; Abbas Agaimy; Raja Atreya; Christoph Becker; Silvio Danese; Jean-François Fléjou; Nikolaus Gaßler; Heike I Grabsch; Arndt Hartmann; Kateřina Kamarádová; Anja A Kühl; Gregory Y Lauwers; Alessandro Lugli; Iris Nagtegaal; Markus F Neurath; Georg Oberhuber; Laurent Peyrin-Biroulet; Timo Rath; Robert Riddell; Carlos A Rubio; Kieran Sheahan; Herbert Tilg; Vincenzo Villanacci; Maria Westerhoff; Michael Vieth
Journal:  Virchows Arch       Date:  2020-12-29       Impact factor: 4.064

4.  Upper gastrointestinal tract involvement in Crohn's disease: A case report.

Authors:  Michael Orrell; Cas van 't Hullenaar; Jonathan Gosling
Journal:  Int J Surg Case Rep       Date:  2021-03-23

5.  Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents.

Authors:  Eun Sil Kim; Mi Jin Kim
Journal:  Clin Exp Pediatr       Date:  2021-09-10

6.  Sex-specific comparison of clinical characteristics and prognosis in Crohn's disease: A retrospective cohort study of 611 patients in China.

Authors:  Zhaoshi Liu; Xiaoyin Bai; Huimin Zhang; Zheng Wang; Hong Yang; Jiaming Qian
Journal:  Front Physiol       Date:  2022-09-29       Impact factor: 4.755

7.  Ustekinumab: "Real-world" outcomes and potential predictors of nonresponse in treatment-refractory Crohn's disease.

Authors:  Peter Hoffmann; Johannes Krisam; Cyrill Wehling; Petra Kloeters-Plachky; Yvonne Leopold; Nina Belling; Annika Gauss
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

8.  Upper gastrointestinal tract involvement is more prevalent in Korean patients with pediatric Crohn's disease than in European patients.

Authors:  Eun Sil Kim; Yiyoung Kwon; Yon Ho Choe; Mi Jin Kim
Journal:  Sci Rep       Date:  2020-11-04       Impact factor: 4.379

Review 9.  Upper Gastrointestinal Tract Involvement in Inflammatory Bowel Diseases: Histologic Clues and Pitfalls.

Authors:  Bence Kővári; Rish K Pai
Journal:  Adv Anat Pathol       Date:  2022-01-01       Impact factor: 3.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.